An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Ankylosing Spondylitis(AS) First published 20/04/2015 Last updated 15/02/2019 EU PAS number:EUPAS9491 Study Ongoing